ArticleCancer medicine2026
Associations Between Circulating Metabolites and Skin Cancer: A Bidirectional Two-Sample Mendelian Randomization Study.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSkin cancer is the most common type of cancer worldwide, categorized into melanoma and non-melanoma types. While genetics play a crucial role in the development of skin cancer, recent developments in metabolomics have revealed that circulating metabolites influence genetic risk profiles.
methodsIn this study, we utilized a bidirectional two-sample Mendelian Randomization (MR) approach, analyzing metabolite datasets from the Canadian Longitudinal Study of Aging (CLSA) and skin cancer datasets from the UK Biobank. Replication analyses were performed with the 10th round of the FinnGen project. Instrumental variables (IVs) were chosen according to established MR criteria and assessed through the Wald ratio, IVW, MR-Egger, and weighted median methods. Various sensitivity analyses were conducted utilizing Cochrane's Q, Egger's intercept, MR-PRESSO, and leave-one-out (LOO) techniques.
resultsAfter meticulous analysis, we identified causal relationships between circulating metabolites and skin cancer risks. Specifically, levels of 1,2-dilinoleoyl-GPE (18:2/18:2), 1-palmitoyl-2-linoleoyl-gpc (16:0/18:2), 1-stearoyl-2-arachidonoyl-gpc (18:0/20:4), 1-stearoyl-2-linoleoyl-gpc (18:0/18:2), and Docosapentaenoate n3 DPA, the ratio of Arachidonate (20:4n6) to oleate to vaccenate (18:1), and Oleoyl-linoleoyl-glycerol (18:1 to 18:2) to linoleoyl-arachidonoyl-glycerol (18:2 to 20:4) were linked to non-melanoma skin cancer, whereas levels of trans-urocanate were causally linked to melanoma of skin, and S-adenosylhomocysteine (SAH) showed a putative association. It should be noted that docosapentaenoate n3 DPA and SAH were each supported by a single SNP and should be interpreted as hypothesis-generating rather than definitive causal evidence. Reverse MR analysis highlighted robust causal relationships with 18 and 10 metabolites and non-melanoma skin cancer and melanoma of skin, respectively.
conclusionThese findings enhance our understanding of skin cancer etiology and risk factors, providing genetic evidence for hypothesis-generating associations that support the development of targeted therapies and aid in the identification of potential biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.